Study comparing hydroxychloroquine and antiviral drug for COVID-19 retracted
The authors of a study comparing hydroxychloroquine and the antiviral agent favipiravir as treatments for COVID-19 have lost the paper after post-publication peer review determined that the data did not support the conclusions. “Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial” appeared in March in Scientific Reports, a … Continue reading Study comparing hydroxychloroquine and antiviral drug for COVID-19 retracted